Zidan Pharma is a promising Stability center , launched in December 2020 and licensed in January 2022. Zidan Pharma has it`s vision to cope with the recent ICH guidelines and EDA guidelines.
Zidan Pharma Mission:
We are aiming to be one of the leading research centers in Egypt & Middle East. Our mission is the technical support for the pharmaceutical companies including Stability Studies, NODCAR files and Method development & Validation.
Company Details
- Founded
- 2020
- Address
- 10 Esmat Mansour, Nasr City,cairo,egypt
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- 6 of october.
- HQ
- Nasr City, Cairo
- Competitors
- International Pharmaceutical Research Center (IPRC), ELRIAH Bioequivalence center, ALChemia for stability and bioequivalence studies, Staba stability center, Future Research Center, Zi Diligence, GRC Genuine Research Center, Bluestabil - Stability Studies Services, PDRTC, Pharmasolutions CRO.
Zidan Pharma For Stability Studies Questions
Zidan Pharma For Stability Studies's LinkedIn profile is https://eg.linkedin.com/company/zidan-pharma-for-stability-studies
Zidan Pharma For Stability Studies's industry is
Pharmaceutical Manufacturing
Zidan Pharma For Stability Studies's top competitors are
International Pharmaceutical Research Center (Iprc),
Elriah Bioequivalence Center,
Alchemia For Stability And Bioequivalence Studies,
Staba Stability Center,
Future Research Center,
Zi Diligence,
Grc Genuine Research Center,
Bluestabil - Stability Studies Services,
Pdrtc,
Pharmasolutions Cro.
Zidan Pharma For Stability Studies's categories are Pharmaceutical Manufacturing
Zidan Pharma For Stability Studies's founding year is 2020
